Baseline characteristics of older adults with AML on CALGB 361101 (Alliance) (n = 96)
Baseline characteristics . | Median (range) or frequency (%) . |
---|---|
Demographics | |
Age (years) median (range) | 72.7 (60.6-92.4) |
% 60-64 | 14.6 |
% 65-69 | 19.8 |
% 70-74 | 24.0 |
% 75-79 | 20.8 |
% ≥80 | 20.8 |
% female | 30.2 |
% white | 90.6 |
% non-Hispanic | 91.7 |
% ECOG performance status ≤1 | 73.9 |
Clinical onset of AML | |
% De novo | 63.2 |
% Therapy-related | 11.6 |
% MDS/AHD | 25.2 |
ELN classification | |
% Normal | 27.4 |
% Intermediate-II | 22.1 |
% Adverse | 38.9 |
% No diagnosis cytogenetics | 11.6 |
Baseline characteristics . | Median (range) or frequency (%) . |
---|---|
Demographics | |
Age (years) median (range) | 72.7 (60.6-92.4) |
% 60-64 | 14.6 |
% 65-69 | 19.8 |
% 70-74 | 24.0 |
% 75-79 | 20.8 |
% ≥80 | 20.8 |
% female | 30.2 |
% white | 90.6 |
% non-Hispanic | 91.7 |
% ECOG performance status ≤1 | 73.9 |
Clinical onset of AML | |
% De novo | 63.2 |
% Therapy-related | 11.6 |
% MDS/AHD | 25.2 |
ELN classification | |
% Normal | 27.4 |
% Intermediate-II | 22.1 |
% Adverse | 38.9 |
% No diagnosis cytogenetics | 11.6 |
AHD, antecedent hematologic disorder; AML, acute myeloid leukemia; ELN, European LeukemiaNet; MDS, myelodysplastic syndromes.